<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> encompasses a wide variety of distinct disease entities </plain></SENT>
<SENT sid="1" pm="."><plain>It is generally more common in developed countries and less common in developing countries </plain></SENT>
<SENT sid="2" pm="."><plain>The East Asia region has one of the lowest incidence rates of malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The incidence of malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> around the world has been increasing at a rate of 3-4% over the last 4 decades, while some stabilization has been observed in developed countries in recent years </plain></SENT>
<SENT sid="4" pm="."><plain>The reasons behind this <z:hpo ids='HP_0002665'>lymphoma</z:hpo> epidemic are poorly understood, although improving diagnostic accuracy, the recent <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> epidemic, an aging world population and the increasing adoption of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-causing behaviors are suggested as contributing factors </plain></SENT>
<SENT sid="5" pm="."><plain>Etiologies of malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> include infectious agents, <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo>, <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo>, exposure to certain organic chemicals, and pharmaceuticals </plain></SENT>
<SENT sid="6" pm="."><plain>The distribution of many subtypes exhibit marked geographic variations </plain></SENT>
<SENT sid="7" pm="."><plain>Compared to the West, T/natural killer (NK) cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (T/NK-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>) and extranodal marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of mucosa-associated lymphoid tissue (MALT <z:hpo ids='HP_0002665'>lymphoma</z:hpo>) are relatively more common, whereas other B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, particularly follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>/small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, are less common in Asia </plain></SENT>
<SENT sid="8" pm="."><plain>Some subtypes of T/NK-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> defined by Epstein-Barr virus association are predominantly Asian diseases, if not exclusively so </plain></SENT>
<SENT sid="9" pm="."><plain>Both ethnic and environmental factors play roles in such diversity </plain></SENT>
<SENT sid="10" pm="."><plain>In this review, we discuss the geographic distribution and etiology of malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, as well as the trend </plain></SENT>
</text></document>